Skip to main navigation Skip to search Skip to main content

Author Correction: Enoxaparin augments alpha-1-antitrypsin inhibition of TMPRSS2, a promising drug combination against COVID-19 (Scientific Reports, (2022), 12, 1, (5207), 10.1038/s41598-022-09133-9)

  • Xiyuan Bai
  • , Ashley M. Buckle
  • , Eszter K. Vladar
  • , Edward N. Janoff
  • , Reeti Khare
  • , Diane Ordway
  • , David Beckham
  • , Lorelenn B. Fornis
  • , Abraham Majluf-Cruz
  • , Randolph V. Fugit
  • , Brian M. Freed
  • , Soohyun Kim
  • , Robert A. Sandhaus
  • , Edward D. Chan
  • Rocky Mountain Regional Veterans Affairs Medical Center
  • National Jewish Health
  • University of Colorado Anschutz Medical Campus
  • Monash University
  • Colorado State University
  • Instituto Mexicano del Seguro Social

Research output: Contribution to journal › Comment/debate

1 Scopus citations

Abstract

The original version of this Article contained an error in the x-axis labels of Figure 5B, C, where in Figure 5B, the spacing of "−" and "+" indicators was incorrect and in Figure 5C, the "−" and "+" indicators were missing. The original Figure 5 and accompanying legend appear below. The original Article has been corrected.

Original languageEnglish
Article number6466
JournalScientific Reports
Volume12
Issue number1
DOIs
StatePublished - Dec 2022

Fingerprint

Dive into the research topics of 'Author Correction: Enoxaparin augments alpha-1-antitrypsin inhibition of TMPRSS2, a promising drug combination against COVID-19 (Scientific Reports, (2022), 12, 1, (5207), 10.1038/s41598-022-09133-9)'. Together they form a unique fingerprint.

Cite this